Management Team

charles-allan

Charles Allan

Chief Executive Officer

EMAIL                                                                                      CONNECT

charles.allan@my01.io                                                       LinkedIn

Charles has a passion for solving problems with MEMS technology. Prior to NXTSENS Microsystems Inc., he completed an M. Eng. at McGill University where he led an engineering team developing high precision MEMS absolute pressure sensors. In his B.Eng., Charles led a team that developed a miniature glaucoma pump. Currently he is leading the commercialization efforts of MY01, leveraging his passions for both business and engineering to ensure optimal user experience and adoption.

edward-j-harvey

Ed Harvey

Chief Medical Officer

EMAIL                                                                                      CONNECT

ed.harvey@my01.io                                                             LinkedIn

Dr Harvey has a rich history of collaboration with basic, clinical and engineering scientists. He is a tenured Professor of Surgery at McGill University.  He is the Director of the Injury Repair and Rehabilitation program (one of only eight programs that make up the entire institute) at the MUHC-RI with over 100 investigators in his group. He is, or has been, editor-in-chief of the Canadian Journal of Surgery; editorial board member of the Journal of Orthopaedic Trauma and OTA International; chairman of the Research Committee and of the Annual Basic Science Course of the OTA; chair of the Trauma Section at the ORS; and president of the Canadian Orthopaedic Association amongst other national and international positions.

george-xereas copy

George Xereas

Chief Technology Officer

EMAIL                                                                                      CONNECT

george.xereas@my01.io                                                   LinkedIn

Dr. Xereas obtained his Ph.D. in Electrical Engineering from McGill University in 2017, under a fellowship from Les Vadasz Foundation – Intel. The results of this work lead to a MEMS oscillator that for the first time achieved compliance with the stringent phase-noise GSM specifications. The intellectual property developed in his PhD resulted in 14 publications, and 2 USPTO utility patent applications. He is a co-founder and Chief Technology Officer of MY01 Inc.

Olivier Bataille

Chief Operations Officer

EMAIL                                                                                      CONNECT

olivier.bataille@my01.io                                                   LinkedIn

Olivier Bataille is a seasoned professional with 25 years of experience in the medical device industry. Olivier was the Vice President of Product Development and Operations at CryoCath Medtronic, Inc. Joining CryoCath in 2005 as the Vice President of Product Development with foreign expert status, Olivier led significant achievements including the release of new robust and reliable systems and devices. As a member of the executive management team, Olivier played a key role in the sale of CryoCath Technologies Inc. to Medtronic Inc. for more than 10 times revenue. Olivier holds a Baccalaureate in Mathematics and Technology, and is a mechanical engineer from Northeastern University in Boston, Massachusetts.

Jay Merkel

Chief Commercial Officer

EMAIL                                                                                      CONNECT

jay.merkel@my01.io                                                            LinkedIn

Jay was recently the Global Franchise Leader at Integra Life Sciences and had responsibility for the $300+ million dollar global wound reconstruction business. She joined Integra as part of the acquisition of ACell Inc where she was the General Manager, Global Surgical and Cardiac. Prior to this role at ACell, Jay had responsibility as the Sr. Director of Marketing focused on downstream marketing activities, communications, market access, and reimbursement. Previously, Jay held marketing leadership positions at Becton Dickinson, Carefusion, Olympus, and B. Braun.

Gino Lambo

Director of Sales

EMAIL                                                                                      CONNECT

gino.lambo@my01.io                                                           LinkedIn

Gino brings over 25 years of Sales Leadership to MY01 with a record of developing and driving high- performing sales teams. Over the years, he has displayed a record of developing high-performing teams through robust training initiatives while also cultivating strong client relationships across the entire sales cycle. His extensive experience with Market leaders such as Stryker, Johnson & Johnson, Halyard Health, Celularity and, most recently, MolecuLight has equipped him with skills to execute comprehensive sales strategies aimed at identifying new opportunities to build a foundation for long-term success. Gino has a Bachelor of Arts degree from the University of St. Thomas – Minnesota.

Simon Sanscartier

VP Europe and Emerging Markets

EMAIL                                                                                      CONNECT

simon.sanscartier@my01.io                                           LinkedIn

CPA by training, Simon started his career working in corporate finance for a public company and then an institutional bank. He followed his career founding 2 SaaS companies: one fail, one exit (2016). He joined MY01 while it was still located in McGill’s lab. As founders were engineers and scientists, Simon was involved in every aspect of the business: Finance, HR, Legal, Marketing, etc.  As the company evolved, Simon’s role refined and focused on funding and European market development. Simon holds a CPA in Accounting and Finance from Université de Sherbrooke.

email

info@my01.io

connect

LinkedIn

Dr Harvey has a rich history of collaboration with basic, clinical and engineering scientists. He is a tenured Professor of Surgery at McGill University.  He is the Director of the Injury Repair and Rehabilitation program (one of only eight programs that make up the entire institute) at the MUHC-RI with over 100 investigators in his group. He is, or has been, editor-in-chief of the Canadian Journal of Surgery; editorial board member of the Journal of Orthopaedic Trauma and OTA International; chairman of the Research Committee and of the Annual Basic Science Course of the OTA; chair of the Trauma Section at the ORS; and president of the Canadian Orthopaedic Association amongst other national and international positions.

email

info@my01.io

connect

LinkedIn

Charles has a passion for solving problems with MEMS technology. Prior to NXTSENS Microsystems Inc., he completed an M. Eng. at McGill University where he led an engineering team developing high precision MEMS absolute pressure sensors. In his B.Eng., Charles led a team that developed a miniature glaucoma pump. Currently he is leading the commercialization efforts of MY01, leveraging his passions for both business and engineering to ensure optimal user experience and adoption.

email

info@my01.io

connect

LinkedIn

Dr. Xereas obtained his Ph.D. in Electrical Engineering from McGill University in 2017, under a fellowship from Les Vadasz Foundation – Intel. The results of this work lead to a MEMS oscillator that for the first time achieved compliance with the stringent phase-noise GSM specifications. The intellectual property developed in his PhD resulted in 14 publications, and 2 USPTO utility patent applications. He is a co-founder and Chief Technology Officer of MY01 Inc.